| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.17 | 0.6 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.6 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |